Study of outcomes after atrial fibrillation catheter ablation
Part of Heart & circulation clinical trials.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be having catheter ablation for atrial fibrillation because symptoms continue despite atrial fibrillation medicines
- Be planning to undergo the ablation procedure as part of this study
- Be able to agree to participate in the study
- Be age 19 or older
- Not have permanent atrial fibrillation that cannot be corrected with electrical cardioversion
- Not have significant heart valve disease (grade 2 or higher) or an enlarged left atrium (left atrial diameter over 60 mm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at what happens after a heart procedure called catheter ablation for atrial fibrillation (an irregular heartbeat). It mainly collects follow-up outcomes to better understand recovery and results for patients.
This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.
This study looks at people with both atrial fibrillation and heart failure to see how they do after a heart procedure called ablation. It aims to find better ways to predict outcomes.
This study follows adults who have had a procedure to treat an irregular heartbeat, to understand who is more likely to have it return. It may help doctors predict risk and plan follow-up after the procedure.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.